We are conducting a clinical research study on an investigational, new version of the Implantable Miniature Telescope (IMT), called the SING IMTTM (Smaller-Incision New- Generation). The study will evaluate improvements in visual acuity and safety of the device in people living with late-stage AMD in both eyes.
The purpose of the implant is to enable qualified patients to recognize and identify objects that they may not otherwise be able to see, as a result of their central vision loss due to AMD.
Already approved in Europe, the SING IMTTM design differs from the original device since it can be inserted through a device delivery system that allows for a smaller incision and less complicated surgery.
Interested in participating?
To qualify to participate, patients must:
Be 65 years of age or older
Have decreased vision associated with late-stage AMD in both eyes.
Have a history of cataracts
Have not yet had cataract surgery in at least one eye
Participation will last up to 15 months, require 5 in-person visits to the study site, up to $100 per study visit. Fill out the form below to be contacted by a Patient Experience Specialist if you qualify.
We are currently conducting this study nationwide with new locations coming soon. Take a look at our current locations below to find out if we have a study location near you.
If transportation is needed, in many situations it can be provided both to and from the study facility at no cost to you.
If you are interested in referring late-stage AMD patients to the CONCERTO study you may have the patient/caregiver call 1-866-393-3767 to discuss eligibility, potential participation, and to answer any questions they may have.
You may also download our patient brochure and patient guide to share with your patients for more information.
Click the button below to download today. For additional questions about the Concerto study, patient referrals and study participation please contact Dr. Rebecca Kammer rkammer@samsaravision.com
Late-stage age-related macular degeneration (AMD) is an advanced form of AMD, where damage to the central vision area of the retina, the macula, occurs. Late-stage AMD is the leading cause of irreversible vision loss for people over 60 years old.
All of your study visits and rehabilitation are covered and there is no need to bill your insurance, and you can continue with your own provider for general care. In fact, you will be compensated for your study-related time and travel.
In many situations transportation can be provided both to and from the study facility.
This is an outpatient procedure performed during cataract surgery, you would go home within a few hours after surgery. The recovery from surgery is relatively rapid. Any discomfort from the surgical procedure generally subsides within several days.
The telescopic implant does not limit your natural eye movements and does not require you to move your entire head, as you have to do with external magnifying appliances. You can use natural eye movements to see things that are close and far away from you, such as reading printed materials or watching television. As a tradeoff to improving central vision, the peripheral (side) vision will be restricted in the eye with the telescope implant. However, your peripheral vision will stay the same as before the surgery in your non-implanted eye.
The telescope is virtually unnoticeable to others because it is implanted totally inside the eye, and mostly covered by the colored portion of the eye (iris).
We are conducting a clinical research study on an investigational, new version of the Implantable Miniature Telescope (IMT), called the SING IMTTM (Smaller-Incision New- Generation).
Key Inclusion Criteria
Key Exclusion Criteria
Sign up for email alerts when new trials and locations are added for a medical condition.
